Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on April 21, 2020, reporting corporate governance changes effective April 21 and April 22, 2020. The Company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market LLC under the symbol "PULM".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and does not contain financial performance data.
Material Changes
- Change in Chairman: Michael J. Higgins succeeded Mark Iwicki as Chairman of the Board effective April 21, 2020. Mr. Iwicki remains a Board member.
- Compensatory Arrangement: In connection with his appointment, Mr. Higgins received an option grant for 15,000 shares at an exercise price of $1.28 per share.
- Board Reclassification: To equalize the size of Board classes, Richard Batycky, Ph.D., resigned as a Class I director and was immediately reappointed as a Class II director effective April 22, 2020. His service is deemed uninterrupted.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirm the impact of the leadership transition on the Company's strategic direction.
- Verify the dilution impact of the 15,000 share option grant to the new Chairman.
- Review the updated Board composition and committee assignments following the reclassification of Dr. Batycky.